Tove Jule Evjen

Title: Tove Jule Evjen: Innovator in Phospholipid Technology

Introduction

Tove Jule Evjen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of phospholipid technology, particularly in the development of innovative pharmaceutical formulations. With a total of five patents to his name, Evjen is recognized for his advancements in the delivery of high doses of krill phospholipids.

Latest Patents

One of Evjen's latest patents involves capsules containing high doses of krill phospholipids. This invention addresses the challenges associated with oral capsules as a dosage form for delivering high dosages of krill phospholipids. By purifying these phospholipids to high levels, it is possible to deliver 700 mg or more per capsule. Another significant patent focuses on liquid phospholipid-containing compositions for the preparation of pharmaceuticals. Current krill oil extracts are liquid at room temperature and contain only about 45-55% phospholipids. Evjen's invention mixes pure phospholipids with viscosity-reducing agents, making them easier to handle and process while retaining the beneficial liquid characteristics of known krill extracts.

Career Highlights

Throughout his career, Tove Jule Evjen has worked with prominent companies in the industry, including Aker Biomarine Antarctic AS and Epitarget AS. His work has been instrumental in advancing the understanding and application of phospholipids in pharmaceuticals.

Collaborations

Evjen has collaborated with several professionals in his field, including Cecilia Leal Lauten and Sigrid L Fossheim. These collaborations have contributed to the success of his innovative projects and patents.

Conclusion

Tove Jule Evjen is a pioneering inventor whose work in phospholipid technology has the potential to transform pharmaceutical formulations. His contributions continue to influence the industry and pave the way for future innovations.